This study examines nonmedical injecting drug use (IDU) among Latinas aged 12 years and older in a nationally
group expressed concern that alarmingly increased rates of IDU were being observed in Hispanic communities, particularly among Latinas. To better understand this problem, we examined the association between Latina IDU and selected demographic characteristics (age, marital status, education, work status) and lifetime use of alcohol, marijuana, and inhalant drugs. The latter have all been cited as possible risk factors for subsequent development of IDU (5) .
We utilized data from the public files of the 1990-1995 National Household Surveys on Drug Abuse (NHSDA). The NHSDA employs a multistage area probability sampling design of civilians aged 12 years and older living in the U.S. (6) . It oversamples Hispanic Americans to increase the precision of estimates for this population subgroup.
In this study, injecting drug use refers to any self-reported past or recent history of injecting of heroin, stimulants, or cocaine for nonmedical reasons. The Latina category is based on respondents' self-reports of their race/ethnic backgrounds. Respondents were grouped into strata or risk sets defined by the block groups and area segments where they were living when sampled, henceforth referred to as neighborhoods. Post-stratified risk sets were created to match Latinas reporting IDU with Latinas reporting no IDU in each neighborhood. This matching strategy was chosen in response to the wide variety of social and geographic backgrounds among Hispanic people (7) . The purpose is to minimize confounding due to differences in community-level characteristics with a suspected impact on IDU prevalence (e.g., norms and attitudes toward drug use generally and toward IDU in particular, drug availability, social disadvantage shared across the neighborhood).
The estimate of lifetime prevalence of IDU among Latinas in the U.S. and its confidence interval were derived by a Taylor series approximation using the statistical package STATA, version 5.0 (8) . This method allows adjustment for variation in sampling weights, post-stratification adjustments to population characteristics, and design effects found in the NHSDA. We used the conditional form of multiple logistic regression to analyze the matched data. This model takes into consideration the post-stratification of respondents into risk sets (9) .
The estimated lifetime prevalence of IDU among Latinas in the U.S. is approximately 1% (SE ϭ 0.0009). Latinas with past or current histories of using marijuana or inhalant drugs were more likely to have reported IDU. Specifically, the odds were an estimated 7.1 times greater for Latinas who reported marijuana use (95%CI: 3.7 to 13.8) and 5.4 times greater for Latinas who reported inhalant drug use (95%CI: 2.4 to 12.3) compared to Latinas who reported never using these agents. IDU among Latinas in this sample was not associated with marital status, employment status, or educational attainment.
A supplementary analysis showed that, compared to neighborhoods in which no Latina reported IDU, those in which at least one Latina did report IDU tended to (1) include a larger share of adults, (2) have fewer Latinas with a high school diploma, and (3) be in the western United States (Table 2) . Neighborhoods with injecting Latinas were somewhat more likely to be located in large metropolitan areas, rather than in small metropolitan or nonmetropolitan areas. This is the first study to examine IDU among a nationally representative sample of Latinas in the U.S. To our knowledge, it is the first epidemiologic study of Latina injecting drug users and community controls. All of the findings are consistent with those from previous studies of IDUs in the general population (5, 10) .
The study has several limitations that affect its interpretation:
• Its cross-sectional design does not permit causal inferences about the association between lifetime use of marijuana and inhalants and injecting drug use. It is likely, though not certain, that injecting drug use follows rather than precedes the use of other drugs. Unfortunately, this issue cannot be addressed with NHSDA data because the age of first IDU is not assessed; • The use of self-reports might introduce reporting bias, perhaps with underreporting of illicit drug use; • Individuals not residing in households are not represented in the data (e.g., homeless persons, incarcerated individuals);
• The category "Latinas" represents an ill-defined grouping of women of widely different geographical and cultural backgrounds (e.g., Puerto Ricans, Cubans, Mexicans). The small sample sizes of the Hispanic American subgroups in the NHSDA forced us to perform aggregate analyses for the combined Latina category. Our sampling design attempted to control confounding due to this diversity by matching IDUs with controls from the same neighborhoods.
These findings provide new details on the associations between IDU and age, marijuana use, and inhalant use among the Latina population of the U.S. However, the mechanisms that explain transitions into IDU remain unknown. We speculate that two common links are a prior drug history and exposure to an opportunity to inject drugs. These hypotheses accord with prior research that showed that drug use occurs in progressive stages, with level of use and consequences inversely related to the age of initiation (11-15). However, prior investigations have paid scant attention to identifying precursors of IDU in Hispanic communities and have generally focused on the behavior of male IDUs. The estimated magnitude of the associations of IDU with marijuana and inhalant drugs is strong enough to warrant a special focus on Latinas who use these agents as part of IDU outreach, prevention, and early intervention services. A surprising aspect of our results is an apparent departure from Kandel's stage theory, in that the link between marijuana use and IDU is independent of the link between inhalant drug use and IDU. The independent association with inhalant drug use is noteworthy because inhalant drugs often are ignored in the planning and consideration of IDU prevention programs.
Finally, there is a recent trend toward more marijuana smoking among Latinas aged 12-17 years. The NHSDA marijuana prevalence estimates for adolescent Latinas were 9.8% in 1992, 11.5% in 1993, 12.9% in 1994, 14.2% in 1995, and 16.6% in 1996 (6). These statistics suggest that the rate of IDU may also rise. The trend warrants close scrutiny.
In view of trends such as these, it is important to identify the ages and situations in which Latinas begin to have opportunities to initiate IDU, the determinants of these opportunities, and why some Latinas act on them while others do not. Interestingly, the results of our secondary analyses hint that Latina IDUs might be more concentrated in large metropolitan areas, and these are the areas where Latinas might have a greater opportunity to inject drugs. This type of variation in the occurrence of IDU can be incorporated in planning IDU prevention initiatives, just as these initiatives now are guided by attention to differences in acculturation, socioeconomic status, religiosity, familialism, extended kinship networks, and folk beliefs among the various Latina groups (7, (16) (17) (18) . Carefully controlled, epidemiologically based prevention trials can examine the mechanisms involved in making the transition to IDU in the course of trying to forestall such transitions.
En el presente estudio se examina el uso de drogas inyectables (UDI) entre latinas de 12 años de edad y mayores en una muestra nacional representativa de hogares estadounidenses. Datos obtenidos de las Encuestas Nacionales Domiciliarias realizadas de 1990 a 1995 revelaron que 154 de un total de 18 335 latinas encuestadas habían referido tener antecedentes de UDI. Se pusieron a prueba diversas hipótesis sobre las variables relacionadas con el UDI mediante una regresión logística múltiple de tipo condicionado destinada a comparar las características de estas usuarias con las de 602 latinas que no usaban drogas inyectables y que se parearon con las usuarias por lugar de residencia. Se estima que en los Estados Unidos de América 1% de las latinas de 12 años o más han usado drogas inyectables para fines no médicos por lo menos en una ocasión. El UDI fue de 4,6 a 6,5 veces más frecuente entre latinas adultas (de 18 a 44 años) al comparar a este grupo con el de latinas de 12 a 17 años (P < 0,05) o de más de 44. El uso estimado de drogas inyectables fue 7,1 veces más frecuente entre las latinas que dijeron haber fumado marijuana y 5,4 más frecuente entre las latinas que dijeron haber inhalado sustancias en comparación con las que no usaban estas drogas (P < 0,01). A la luz de los estudios recientes que señalan que el UDI es un serio problema de salud pública para la población de latinas en los Estados Unidos, las asociaciones observadas representan los primeros pasos de una tentativa por entender cuáles son los subgrupos de latinas más afectados por el UDI y por los factores de riesgo o causas subyacentes que llevan a esta conducta. Se llama la atención de los lectores a un error de traducción que aparece en la figura 1, p. 173. La primera, de izquierda a derecha, de las tres flechas que están dentro de la figura debe decir "Vacunación de puesta al día" en vez de "Vacunación de cobertura básica". Lamentamos el error, que ha ocurrido por entera responsabilidad de nuestra redacción.
